# Universal Corp: financial statements, quarterly

UVV · NYSE · CIK 102037 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/uvv.md) · [Financials](/companies/uvv/financials.md) · [Filings](/companies/uvv/filings.md) · [Insiders](/companies/uvv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uvv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [636](/filings/0000102037-25-000018.md) | [813](/filings/0000102037-25-000019.md) | [756 d](/filings/0001628280-26-039511.md) | [596](/filings/0000102037-25-000053.md) | [708](/filings/0001628280-25-049596.md) | [928](/filings/0001628280-26-006203.md) | [690 d](/filings/0001628280-26-039511.md) | [593](/filings/0001628280-26-053393.md) | [749](/filings/0001628280-25-049596.md) | [853](/filings/0001628280-26-006203.md) | [690 d](/filings/0001628280-26-039511.md) | [520](/filings/0001628280-26-053393.md) |
| Cost of revenue | $m | [507](/filings/0000102037-25-000018.md) | [655](/filings/0000102037-25-000019.md) | [620 d](/filings/0001628280-26-039511.md) | [501](/filings/0000102037-25-000053.md) | [568](/filings/0001628280-25-049596.md) | [744](/filings/0001628280-26-006203.md) | [586 d](/filings/0001628280-26-039511.md) | [480](/filings/0001628280-26-053393.md) | [614](/filings/0001628280-25-049596.md) | [702](/filings/0001628280-26-006203.md) | [617 d](/filings/0001628280-26-039511.md) | [441](/filings/0001628280-26-053393.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [73.8](/filings/0000102037-25-000018.md) | [78.6](/filings/0000102037-25-000019.md) | [82.7 d](/filings/0001628280-26-039511.md) | [78.7](/filings/0000102037-25-000053.md) | [63.8](/filings/0001628280-25-049596.md) | [89.5](/filings/0001628280-26-006203.md) | [73.2 d](/filings/0001628280-26-039511.md) | [79.2](/filings/0001628280-26-053393.md) | [72.2](/filings/0001628280-25-049596.md) | [76.9](/filings/0001628280-26-006203.md) | [72.4 d](/filings/0001628280-26-039511.md) | [80.8](/filings/0001628280-26-053393.md) |
| Operating income | $m | [55.3](/filings/0000102037-25-000018.md) | [87.5](/filings/0000102037-25-000019.md) | [68.2 d](/filings/0001628280-26-039511.md) | [17.2](/filings/0000102037-25-000053.md) | [68.7](/filings/0001628280-25-049596.md) | [104](/filings/0001628280-26-006203.md) | [42.8 d](/filings/0001628280-26-039511.md) | [33.8](/filings/0001628280-26-053393.md) | [67.6](/filings/0001628280-25-049596.md) | [82.0](/filings/0001628280-26-006203.md) | [(15.0) d](/filings/0001628280-26-039511.md) | [2.3](/filings/0001628280-26-053393.md) |
| Interest expense | $m | [17.1](/filings/0000102037-25-000018.md) | [15.5](/filings/0000102037-25-000019.md) | [18.2 d](/filings/0001628280-26-039511.md) | [20.7](/filings/0000102037-25-000053.md) | [21.3](/filings/0001628280-25-049596.md) | [19.3](/filings/0001628280-26-006203.md) | [18.3 d](/filings/0001628280-26-039511.md) | [17.8](/filings/0001628280-26-053393.md) | [20.4](/filings/0001628280-25-049596.md) | [17.3](/filings/0001628280-26-006203.md) | [18.6 d](/filings/0001628280-26-039511.md) | [16.5](/filings/0001628280-26-053393.md) |
| Income tax | $m | [8.4](/filings/0000102037-25-000018.md) | [14.5](/filings/0000102037-25-000019.md) | [9.6 d](/filings/0001628280-26-039511.md) | [0.7](/filings/0000102037-25-000053.md) | [13.6](/filings/0001628280-25-049596.md) | [20.2](/filings/0001628280-26-006203.md) | [6.4 d](/filings/0001628280-26-039511.md) | [5.3](/filings/0001628280-26-053393.md) | [11.2](/filings/0001628280-25-049596.md) | [25.3](/filings/0001628280-26-006203.md) | [4.8 d](/filings/0001628280-26-039511.md) | [(4.5)](/filings/0001628280-26-053393.md) |
| Net income | $m | [28.1](/filings/0000102037-25-000018.md) | [53.2](/filings/0000102037-25-000019.md) | [40.3 d](/filings/0001628280-26-039511.md) | [0.1](/filings/0000102037-25-000053.md) | [25.9](/filings/0001628280-25-049596.md) | [59.6](/filings/0001628280-26-006203.md) | [9.3 d](/filings/0001628280-26-039511.md) | [8.5](/filings/0001628280-26-053393.md) | [34.2](/filings/0001628280-25-049596.md) | [33.2](/filings/0001628280-26-006203.md) | [(43.3) d](/filings/0001628280-26-039511.md) | [(5.0)](/filings/0001628280-26-053393.md) |
| Diluted EPS | $ per share | [1.12](/filings/0000102037-25-000018.md) | [2.12](/filings/0000102037-25-000019.md) | not reported | [0.01](/filings/0000102037-25-000053.md) | [1.03](/filings/0001628280-25-049596.md) | [2.37](/filings/0001628280-26-006203.md) | not reported | [0.34](/filings/0001628280-26-053393.md) | [1.36](/filings/0001628280-25-049596.md) | [1.32](/filings/0001628280-26-006203.md) | not reported | [(0.20)](/filings/0001628280-26-053393.md) |
| Basic EPS | $ per share | [1.13](/filings/0000102037-25-000018.md) | [2.14](/filings/0000102037-25-000019.md) | not reported | [0.01](/filings/0000102037-25-000053.md) | [1.04](/filings/0001628280-25-049596.md) | [2.39](/filings/0001628280-26-006203.md) | not reported | [0.34](/filings/0001628280-26-053393.md) | [1.36](/filings/0001628280-25-049596.md) | [1.33](/filings/0001628280-26-006203.md) | not reported | [(0.20)](/filings/0001628280-26-053393.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [99.7](/filings/0000102037-25-000018.md) | [74.1](/filings/0000102037-25-000019.md) | [55.6](/filings/0000102037-25-000028.md) | [102](/filings/0000102037-25-000053.md) | [80.1](/filings/0001628280-25-049596.md) | [215](/filings/0001628280-26-006203.md) | [260](/filings/0001628280-26-039511.md) | [178](/filings/0001628280-26-053393.md) | [88.7](/filings/0001628280-25-049596.md) | [85.2](/filings/0001628280-26-006203.md) | [62.2](/filings/0001628280-26-053393.md) | [174](/filings/0001628280-26-053393.md) |
| Current assets | $m | [2,048](/filings/0000102037-25-000018.md) | [2,014](/filings/0000102037-25-000019.md) | [2,103](/filings/0000102037-25-000028.md) | [2,198](/filings/0000102037-25-000053.md) | [2,212](/filings/0001628280-25-049596.md) | [2,216](/filings/0001628280-26-006203.md) | [2,156](/filings/0001628280-26-039511.md) | [2,346](/filings/0001628280-26-053393.md) | [2,240](/filings/0001628280-25-049596.md) | [2,183](/filings/0001628280-26-006203.md) | [1,972](/filings/0001628280-26-053393.md) | [2,240](/filings/0001628280-26-053393.md) |
| Total assets | $m | [2,862](/filings/0000102037-25-000018.md) | [2,834](/filings/0000102037-25-000019.md) | [2,937](/filings/0001628280-26-039511.md) | [3,033](/filings/0000102037-25-000053.md) | [3,046](/filings/0001628280-25-049596.md) | [3,040](/filings/0001628280-26-006203.md) | [2,990](/filings/0001628280-26-039511.md) | [3,189](/filings/0001628280-26-053393.md) | [3,070](/filings/0001628280-25-049596.md) | [3,018](/filings/0001628280-26-006203.md) | [2,767](/filings/0001628280-26-053393.md) | [3,035](/filings/0001628280-26-053393.md) |
| Current liabilities | $m | [701](/filings/0000102037-25-000018.md) | [625](/filings/0000102037-25-000019.md) | [711](/filings/0000102037-25-000028.md) | [846](/filings/0000102037-25-000053.md) | [849](/filings/0001628280-25-049596.md) | [819](/filings/0001628280-26-006203.md) | [750](/filings/0001628280-26-039511.md) | [943](/filings/0001628280-26-053393.md) | [829](/filings/0001628280-25-049596.md) | [751](/filings/0001628280-26-006203.md) | [564](/filings/0001628280-26-053393.md) | [871](/filings/0001628280-26-053393.md) |
| Total liabilities | $m | [1,444](/filings/0000102037-25-000018.md) | [1,375](/filings/0000102037-25-000019.md) | [1,458](/filings/0000102037-25-000028.md) | [1,589](/filings/0000102037-25-000053.md) | [1,588](/filings/0001628280-25-049596.md) | [1,549](/filings/0001628280-26-006203.md) | [1,489](/filings/0001628280-26-039511.md) | [1,690](/filings/0001628280-26-053393.md) | [1,566](/filings/0001628280-25-049596.md) | [1,492](/filings/0001628280-26-006203.md) | [1,306](/filings/0001628280-26-053393.md) | [1,613](/filings/0001628280-26-053393.md) |
| Long-term debt | $m | [617](/filings/0000102037-25-000018.md) | [617](/filings/0000102037-25-000019.md) | [617](/filings/0000102037-25-000028.md) | [618](/filings/0000102037-25-000053.md) | [618](/filings/0001628280-25-049596.md) | [618](/filings/0001628280-26-006203.md) | [618](/filings/0001628280-26-039511.md) | [618](/filings/0001628280-26-053393.md) | [618](/filings/0001628280-25-049596.md) | [617](/filings/0001628280-26-006203.md) | [617](/filings/0001628280-26-053393.md) | [617](/filings/0001628280-26-053393.md) |
| Current portion of debt | $m | [0.0](/filings/0000102037-25-000018.md) | [0.0](/filings/0000102037-25-000019.md) | [0.0](/filings/0000102037-25-000028.md) | [0.0](/filings/0000102037-25-000053.md) | [0.0](/filings/0001628280-25-049596.md) | [0.0](/filings/0001628280-26-006203.md) | [0.0](/filings/0001628280-26-039511.md) | [0.0](/filings/0000102037-25-000053.md) | [0.0](/filings/0001628280-25-049596.md) | [0.0](/filings/0001628280-26-006203.md) | [0.0](/filings/0001628280-26-039511.md) | not reported |
| Short-term borrowings | $m | [301](/filings/0000102037-25-000018.md) | [365](/filings/0000102037-25-000019.md) | [417](/filings/0000102037-25-000028.md) | [581](/filings/0000102037-25-000053.md) | [579](/filings/0001628280-25-049596.md) | [539](/filings/0001628280-26-006203.md) | [455](/filings/0001628280-26-039511.md) | [621](/filings/0001628280-26-053393.md) | [540](/filings/0001628280-25-049596.md) | [462](/filings/0001628280-26-006203.md) | [288](/filings/0001628280-26-053393.md) | [567](/filings/0001628280-26-053393.md) |
| Shareholders' equity | $m | [1,384](/filings/0000102037-25-000018.md) | [1,417](/filings/0000102037-25-000019.md) | [1,437](/filings/0000102037-25-000028.md) | [1,413](/filings/0000102037-25-000053.md) | [1,421](/filings/0001628280-25-049596.md) | [1,451](/filings/0001628280-26-006203.md) | [1,459](/filings/0001628280-26-039511.md) | [1,459](/filings/0001628280-26-053393.md) | [1,470](/filings/0001628280-25-049596.md) | [1,483](/filings/0001628280-26-006203.md) | [1,415](/filings/0001628280-26-053393.md) | [1,389](/filings/0001628280-26-053393.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [114 d](/filings/0000102037-25-000018.md) | [(57.3) d](/filings/0000102037-25-000019.md) | [(27.9) d](/filings/0001628280-26-039511.md) | [(62.4)](/filings/0000102037-25-000053.md) | [15.0 d](/filings/0001628280-25-049596.md) | [216 d](/filings/0001628280-26-006203.md) | [159 d](/filings/0001628280-26-039511.md) | [(205)](/filings/0001628280-26-053393.md) | [32.7 d](/filings/0001628280-25-049596.md) | [114 d](/filings/0001628280-26-006203.md) | [187 d](/filings/0001628280-26-039511.md) | [(117)](/filings/0001628280-26-053393.md) |
| Capital expenditure | $m | [14.7 d](/filings/0000102037-25-000018.md) | [15.1 d](/filings/0000102037-25-000019.md) | [18.3 d](/filings/0001628280-26-039511.md) | [22.7](/filings/0000102037-25-000053.md) | [16.0 d](/filings/0001628280-25-049596.md) | [16.1 d](/filings/0001628280-26-006203.md) | [7.7 d](/filings/0001628280-26-039511.md) | [12.1](/filings/0001628280-26-053393.md) | [9.0 d](/filings/0001628280-25-049596.md) | [19.2 d](/filings/0001628280-26-006203.md) | [8.5 d](/filings/0001628280-26-039511.md) | [15.9](/filings/0001628280-26-053393.md) |
| Dividends paid | $m | [19.7 d](/filings/0000102037-25-000018.md) | [19.6 d](/filings/0000102037-25-000019.md) | [19.6 d](/filings/0001628280-26-039511.md) | [19.7](/filings/0000102037-25-000053.md) | [20.0 d](/filings/0001628280-25-049596.md) | [20.0 d](/filings/0001628280-26-006203.md) | [20.0 d](/filings/0001628280-26-039511.md) | [20.0](/filings/0001628280-26-053393.md) | [20.4 d](/filings/0001628280-25-049596.md) | [20.4 d](/filings/0001628280-26-006203.md) | [20.4 d](/filings/0001628280-26-039511.md) | [20.4](/filings/0001628280-26-053393.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0000102037-25-000019.md) | [0.0 d](/filings/0001628280-26-039511.md) | not reported | not reported | [0.0 d](/filings/0000102037-25-000019.md) | [0.0 d](/filings/0001628280-26-039511.md) | [0.0](/filings/0001628280-26-053393.md) | not reported | not reported | not reported | [2.7](/filings/0001628280-26-053393.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.9](/filings/0000102037-23-000058.md) | [24.9](/filings/0000102037-24-000007.md) | [24.8](/filings/0000102037-24-000031.md) | [25.0](/filings/0000102037-25-000018.md) | [25.1](/filings/0000102037-25-000019.md) | [25.1](/filings/0000102037-25-000053.md) | [25.1](/filings/0001628280-25-049596.md) | [25.1](/filings/0001628280-26-006203.md) | [25.1](/filings/0001628280-26-053393.md) | [25.2](/filings/0001628280-25-049596.md) | [25.2](/filings/0001628280-26-006203.md) | [25.1](/filings/0001628280-26-053393.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,899,257 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053393.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.